CTOs on the Move

JSJ Pharmaceuticals

www.jsjpharm.com

 
JSJ Pharmaceuticals is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.jsjpharm.com
  • 140 E Bay St Ste C
    Charleston, SC USA 29401
  • Phone: 843.965.8333

Executives

Name Title Contact Details

Similar Companies

Rodeo Dental & Orthodontics

Rodeo Dental & Orthodontics has 100+ dental experts from several specialties! Your one-stop shopping in STYLE for all your oral health needs.

Concord

Concord is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innoviant

Innoviant, Inc. is a Wausau, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sano Informed Prescribing

Sano Informed Prescribing, Inc. is creating game-changing personal and population health management capabilities, previously unattainable in the healthcare market, by revolutionizing medication therapy through the fast, clinically precise detection of medications in patients. The vision of Sano Informed Prescribing is to improve individual and population health; enable healthcare professionals to evaluate, adjust and implement best possible medication therapy programs; and reduce the costs associated with quality healthcare. Sano Informed Prescribing’s mission is to ensure that every patient receives the most effective drug therapy possible. We will do this by providing precise, patient-specific medication analyses that empower healthcare professionals to tailor care; achieve optimal patient health outcomes and satisfaction; and impact overall healthcare costs.

Prilenia

We are a clinical stage biotech startup, led by Michael Hayden, MD, PhD., together with a highly experienced team with a track record of success. Michael is the founder of five biotech companies and was previously President of Global R&D and Chief Scientific Officer at Teva. He has directed the development of multiple innovative drug products leading to 35 approvals between 2012-2018.